Pharmaceuticals

The Quinine Market Is Evolving Due To The Increasing Prevalence Of Thromboembolic Conditions Driving Growth Of The Due To Rising Health Risks In Aging Populations

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Quinine Market From 2026 To 2030?

The quinine market size has shown substantial growth in recent years. Its expansion is anticipated to be from $2.45 billion in 2025 to $2.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. The historical increase can be ascribed to traditional reliance on cinchona bark extraction, limited availability of purified quinine, widespread use in malaria treatment, its utilization in home remedies and tonic beverages, and the adoption in oral formulations.

The quinine market size is anticipated to undergo significant expansion in the next few years, projected to reach $3.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.8%. This expansion during the forecast period is driven by technological advancements in quinine synthesis and purification, an increasing demand for pharmaceutical-grade quinine, the broadening reach of malaria control programs, the growth of functional beverages incorporating quinine, and enhanced investment in antimalarial research and development. Key trends in the upcoming period include a rising preference for natural antimalarial compounds, the expanding utilization of quinine in tonic beverages and functional drinks, the creation of pharmaceutical-grade quinine derivatives, heightened awareness regarding malaria prevention and treatment, and a concentrated focus on regulatory compliance and quality standards for quinine products.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24676&type=smp

What Leading Drivers Are Supporting The Quinine Market Expansion?

The increasing incidence of malaria is projected to drive the expansion of the quinine market in the foreseeable future. Malaria is an infectious illness caused by Plasmodium parasites, transmitted to humans primarily through the bites of infected female Anopheles mosquitoes. The rise in malaria cases is attributed to escalating global temperatures, which extend both the habitat range and breeding periods of these malaria-carrying mosquitoes. Quinine functions as a powerful antimalarial medication, treating the disease by disrupting the parasite’s capacity to digest hemoglobin in red blood cells, thereby inhibiting its growth and survival. For example, the UK Health Security Agency reported in April 2024 that England saw 2,004 confirmed cases of malaria in 2023, an increase from 1,369 cases in 2022. Thus, the growing prevalence of malaria is boosting the growth of the quinine market.

Which Segment Categories Are Included In The Quinine Market Segment Analysis?

The quinine market covered in this report is segmented –

1) By Product: Quinine Sulphate, Quinine Hydrochloride, Quinine Gluconate, Quinine Bisulphate

2) By Administration: Oral Administration, Intramuscular Administration, Intravenous Administration, Other Administrations

3) By Application: Malaria Treatment, Nocturnal Leg Cramps

4) By Enduser: Hospitals, Clinics, Other Endusers

Who Are The Active Companies Shaping The Quinine Market?

Major companies operating in the quinine market are Teva Pharmaceutical Industries Ltd., Schweppes Australia Proprietary Limited, The United States Pharmacopeial Convention Inc., Chempro Pharma Private Limited, Taj Pharmaceuticals Ltd., Swiss Parenterals Private Limited, Leocorno Enterprises Private Limited, Healthy Inc., Jai Radhe Sales, Adooq Bioscience LLC, Akhil Healthcare Pvt Ltd., Van Wankum Ingredients B.V., Shreeji Pharma International, Prism Industries Private Limited, Lavina Pharmaceuticals Pvt Ltd., A. B. Enterprises, Spark Lifesciences Private Limited, Sihauli Chemicals Private Limited, Shanghai Nianxing Industrial Co. Ltd., Sakhiya Pharma Chem

Get The Full Quinine Market Report:

https://www.thebusinessresearchcompany.com/report/quinine-global-market-report

Which Region Is The Top Contributor To The Quinine Market By Share?

North America was the largest region in the quinine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quinine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Quinine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/quinine-global-market-report

Browse Through More Reports Similar to the Global Quinine Market 2026, By The Business Research Company

Malaria Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Malaria Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Chitosan Market Report 2026

https://www.thebusinessresearchcompany.com/report/chitosan-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795